Table 2.
Baseline demographics and clinical characteristics of patients in intervention and control arms
| Characteristic | Intervention arm | Control arm |
|---|---|---|
| (n = 57) | (n = 57) | |
| Number (%) | Number (%) | |
| Sex: female | 21 (36.8) | 36 (63.2) |
| Pre-existing comorbidity: | ||
| Myocardial infarction | 0 | 3 (5.3) |
| Renal | 1 (1.8) | 0 |
| Diabetes mellitus | 13 (22.8) | 4 (7.01) |
| Carcinoma | 4 (7.01) | 10 (17.5) |
| Respiratory | 9 (15.8) | 9 (15.8) |
| Cerebrovascular Accident | 5 (8.8) | 7 (12.3) |
| Hypertension | 17 (29.8) | 19 (33.3) |
| 1 co-morbidity | 19 (33.3) | 26 (45.6) |
| 2 co-morbidities | 17 (29.8) | 13 (22.8) |
| 3 co-morbidities | 10 (17.5) | 6 (7.0) |
| 4 co-morbidities | 2 (3.5) | 0 |
| Age in years: | ||
| Median | 49.00 | 45.00 |
| Range | 14-76 | 14-84 |
| Interquartile range | 29 | 26 |
Marginally more patients in the intervention group (48 out of 57, 84.2%) had up to four comorbidities than those in the control group (45 out of 57, 78.9%).